Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Short term Debt (2018 - 2026)

Rockwell Medical filings provide 10 years of Short term Debt readings, the most recent being $1.8 million for Q3 2025.

  • On a quarterly basis, Short term Debt fell 20.84% to $1.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.8 million, a 20.84% decrease, with the full-year FY2024 number at $2.4 million, down 5.16% from a year prior.
  • Short term Debt hit $1.8 million in Q3 2025 for Rockwell Medical, down from $2.5 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $7.4 million in Q4 2021 to a low of $171000.0 in Q1 2021.
  • Median Short term Debt over the past 5 years was $2.5 million (2023), compared with a mean of $3.5 million.
  • Biggest five-year swings in Short term Debt: surged 4921.83% in 2021 and later tumbled 77.9% in 2022.
  • Rockwell Medical's Short term Debt stood at $7.4 million in 2021, then tumbled by 77.9% to $1.6 million in 2022, then soared by 53.28% to $2.5 million in 2023, then decreased by 5.16% to $2.4 million in 2024, then fell by 24.08% to $1.8 million in 2025.
  • The last three reported values for Short term Debt were $1.8 million (Q3 2025), $2.5 million (Q2 2025), and $2.4 million (Q1 2025) per Business Quant data.